Clinical Trials · NCT06005012
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- University of California, San Diego
- Enrollment
- 120
- Start date
- Jul 2023
- Locations
- 1 site, United States
- Primary endpoint
- Change in fibrosis due to NAFLD